RxDoctor Payments Data

Kristin Brausch

Family · Cincinnati, OHNPI 1265183867

Payments from drug & device makers

$375in general payments, 2019–2025

Across 22 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$134
  • Novo Nordisk$55
  • Dexcom, Inc.$43
  • Pfizer$29
  • Abeona Therapeutics, Inc.$22
  • Lemaitre Vascular, Inc.$20
  • plus $73 from 5 others

What the payments were for

  • Food & beverage$375100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$375 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$17,230
Medicare patients
81
Services billed
274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$43,442
JanuviaSitagliptin Phosphate30$36,729
FarxigaDapagliflozin Propanediol38$34,962
JardianceEmpagliflozin25$30,207
EliquisApixaban23$24,071
MounjaroTirzepatide21$23,500
TrulicityDulaglutide17$17,578
XareltoRivaroxaban12$14,607
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,614
Breo ElliptaFluticasone/Vilanterol13$9,725
Pravastatin Sodium148$2,197
Atorvastatin Calcium223$1,656
Omeprazole102$1,561
Albuterol Sulfate HfaAlbuterol Sulfate49$1,472
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,433

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$55$43,44236 claims
PfizerEliquis$29$24,07123 claims
GSKTrelegy Ellipta, Breo Ellipta$14$20,33928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →